Please Wait
Applying Filters...
menu
    • menu

    Digital Content for MolPort-001-783-551

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    MolPort-001-783-551

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 294,241Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Esteve Pharmaceuticals' Thiotepa Riemser (Thiotepa) Approved In Europe
    Esteve Pharmaceuticals' Thiotepa Riemser (Thiotepa) Approved In Europe

    16 Feb 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/thiotepa-riemser-epar-medicine-overview_en.pdf

    EMA
    16 Feb 2023
    Share Share
    Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa
    Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa

    29 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220729005063/en

    BUSINESSWIRE
    29 Jul 2022
    Share Share
    Gland Pharma's Generic Thiotepa Receives Approval in the U.S.
    Gland Pharma's Generic Thiotepa Receives Approval in the U.S.

    03 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214222

    FDA
    03 Jan 2022
    Share Share
    Health Canada Issues Recall of Methapharm Inc's Tepadina
    Health Canada Issues Recall of Methapharm Inc's Tepadina

    11 May 2020

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-methapharm-incs-tepadina-1589269138.pdf

    HEALTH CANADA
    11 May 2020
    Share Share
    MSN`s Generic Dofetilide Receives Approval in US
    MSN`s Generic Dofetilide Receives Approval in US

    06 Mar 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213049

    FDA
    06 Mar 2020
    Share Share
    Dr. Reddys Labs Generic Thiotepa Receives Approval In US
    Dr. Reddys Labs Generic Thiotepa Receives Approval In US

    08 May 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210337

    FDA
    08 May 2018
    Share Share